DRPRF Financial Statements From 2010 to 2026

DRPRF Stock  USD 53.65  1.31  2.50%   
Dr Ing's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dr Ing's valuation are provided below:
Dr Ing hc does not right now have any fundamental measures for analysis.
Check Dr Ing financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Ing's main balance sheet or income statement drivers, such as , as well as many indicators such as . DRPRF financial statements analysis is a perfect complement when working with Dr Ing Valuation or Volatility modules.
  
This module can also supplement various Dr Ing Technical models . Check out the analysis of Dr Ing Correlation against competitors.

Dr Ing hc Company Shares Owned By Institutions Analysis

Dr Ing's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

More About Shares Owned By Institutions | All Equity Analysis

Current Dr Ing Shares Owned By Institutions

    
  13.52 %  
Most of Dr Ing's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Ing hc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition

Based on the latest financial disclosure, 13.52% of Dr Ing hc are shares owned by institutions. This is 77.51% lower than that of the Consumer Cyclical sector and 13.94% lower than that of the Auto Manufacturers industry. The shares owned by institutions for all United States stocks is 65.52% higher than that of the company.

Dr Ing hc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Ing competition to find correlations between indicators driving Dr Ing's intrinsic value. More Info.
Dr Ing hc is rated # 4 in profit margin category among its peers. It is rated # 2 in operating margin category among its peers reporting about  1.45  of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Ing's earnings, one of the primary drivers of an investment's value.

About Dr Ing Financial Statements

Dr Ing stakeholders use historical fundamental indicators, such as Dr Ing's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dr Ing investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dr Ing's assets and liabilities are reflected in the revenues and expenses on Dr Ing's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dr Ing hc. Please read more on our technical analysis and fundamental analysis pages.
Porsche AG engages in automotive and financial services businesses. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH. Dr ING is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in DRPRF Pink Sheet

Dr Ing financial ratios help investors to determine whether DRPRF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRPRF with respect to the benefits of owning Dr Ing security.